ComplianceOnline

Post Market Surveillance for Medical Devices

Instructor: Daniel O Leary
Product ID: 702377
Training Level: Intermediate
  • 8
  • June 2017
    Thursday
  • 10:00 AM PDT | 01:00 PM EDT
    Duration: 90 Min

Live Online Training
June 08, Thursday 10:00 AM PDT | 01:00 PM EDT | Duration: 90 Min

$229.00
One Dial-in One Attendee
$479.00
Group-Max. 10 Attendees/Location
(For multiple locations contact Customer Care)

recorded version

$279.00
1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section 48 hrs after completion of Live training

Training CD

$379.00
One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days after completion of Live training

Combo Offers

Live + Recorded Version

$379.00

Live + Training CD

$479.00

Customer Care

Fax: +1-650-565-8542

Email: customercare@complianceonline.com

Read Frequently Asked Questions

This 90-minute webinar covers all aspects of post market surveillance (PMS) for medical devices. It will direct you to the specific documents for the detailed information you need for an effective post-market surveillance system.

Why Should You Attend:

Post market surveillance is changing, not only in the US, but also in the EU and Canada. New rules and regulations are emerging in the countries where the devices manufacturers market their products. The sheer volume of rules and regulations can be daunting, but the differences in each geographic market can be scary.

This webinar explains the aspects of post market surveillance that will help you understand and implement them. The webinar explains the use of post-market surveillance in maintaining your risk management file (ISO 14971) and updating your clinical evaluation (MDD Annex X). In addition, the webinar compares and contrast the rules for adverse event reporting in the US, EU, and Canada.

Areas Covered in the Webinar:

  • The Structure of Post Market Surveillance
  • US System
    • Complaints (QSR)
    • Medical Device Reports
    • Corrections and Removals
  • International Systems
    • Complaints (ISO 13485)
    • EU Vigilance
    • EU FSCA and FSN
    • Canada Adverse Event Reporting
  • Post Production Information Collection
    • Risk Management (ISO 14971)
    • Clinical Evaluation (MDD Annex X)

Who Will Benefit:

This webinar provides information that is valuable for people involved in monitoring product performance, maintaining risk management files, updating clinical evaluation, and reporting to regulatory agencies. This typically includes:

  • Quality Managers
  • Regulatory Affairs Managers
  • Risk Managers
  • Design Control Managers
Instructor Profile:
Daniel O Leary

Daniel O Leary
President, Ombu Enterprises, LLC

Daniel O'Leary, is the President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence, focused on analytic skills and a systems approach to operations management. Dan has more than 30 years experience in quality, operations, and program management in regulated industries including aviation, defense, medical devices, and clinical labs. He has a Masters Degree in Mathematics; is an ASQ certified Biomedical Auditor, Quality Auditor, Quality Engineer, Reliability Engineer, and Six Sigma Black Belt; and is certified by APICS in Resource Management.

Topic Background:

Post-market surveillance is a requirement for medical device manufacturers. PMS can be complicated, but by breaking it down into its parts, it can be accessible. With the understanding of the parts, you can develop and implement a comprehensive system that will help you stay in compliance.

The first phase involves learning information about your product in the market. This information can from customer feedback, complaints, etc. In addition, you can learn about similar products from literature searches and adverse event databases. This information is the basis to update the ISO 14971 Risk Management File as well as MDD Annex X Clinical Evaluation.

The second phase concerns adverse events that you must report to regulators. The reporting requirements and report timing differ in the geographic markets. An event may have a reporting cycle of 10 days in the EU and 30 days in the US.

The third phase concerns modification or removal of a product from the market.

The webinar covers all three phases, provides a high-level overview of the requirements and directs you to the specific documents for the detailed information you need for an effective post-market surveillance system.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
ComplianceOnline Medical Device Summit 2017

Refund Policy

Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.

Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.

If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.

We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@complianceonline.com call +1-888-717-2436 (Toll Free).

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed
    Loading